Updates

RLG which represents clients with claims for injuries and birth defects allegedly caused by selective serotonin reuptake inhibitor antidepressants (SSRIs) including Zoloft is helping to publicize the results of a study showing an increased mortality rate during the perioperative period for patients who are on an SSRI. A study reported online… Read more

The Rottenstein Law Group which represents clients with injuries allegedly caused by antidepressants in the selective serotonin reuptake inhibitor (SSRI) category is helping to make the public aware of the results of the most recent study finding that a pregnant woman’s use of SSRIs might increase her chances of miscarrying and her child’s… Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries allegedly caused by drugs in the selective serotonin reuptake inhibitor (SSRI) class of antidepressants is helping to make the public aware of the results of a recent study finding that use of SSRIs might confer a small but statistically significant risk… Read more

A study conducted at the University of Vancouver in British Columbia showed that infants were more likely to suffer from speech development delays if they were born to mothers who while they were pregnant either: (1) suffered from untreated depression or; (2) took a medication like Zoloft to treat their depression. These… Read more

The Rottenstein Law Group which represents clients who allege they suffered birth defects as a result of their mothers having taken Zoloft while pregnant notes a federal court judge’s decision to remand to West Virginia state court 18 cases filed by minors who claim they suffered birth defects as a result of Zoloft…. Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries and birth defects caused by the antidepressant Zoloft is helping to publicize the status of the Zoloft Multidistrict Litigation pending in the U.S. District Court for the Eastern District of Pennsylvania. As of August 2012 there were… Read more

The Rottenstein Law Group which represents clients whose children have suffered birth defects allegedly caused by the selective serotonin reuptake inhibitor (SSRI) antidepressant Paxil applauds four members of the House of Representatives for proposing legislation to require drug and medical device companies to register with—and report the results of all human clinical trials… Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries and birth defects caused by the Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants  sold as Zoloft and Paxil has learned of new research showing that women who take SSRIs might face increased risk of giving birth to infants… Read more

The Rottenstein Law Group has learned of research suggesting that critically ill patients who are prescribed SSRIs after being admitted a hospital’s intensive care unit (ICU) are more likely to die than patients who are not taking a drug in the SSRI class. According to a release issued by the American Thoracic… Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries and birth defects caused by the Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants  sold as Zoloft and Paxil has learned of research showing that women who take SSRIs while they are pregnant might be increasing their chances of going into early labor… Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of Zoloft a member of the selective serotonin re-uptake inhibitor (SSRI) class of antidepressants is chagrined—but not surprised—by a recently published paper in which a group of researchers state that the harmful side effects of commonly prescribed antidepressants… Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries and birth defects caused by the Selective Serotonin Reuptake Inhibitors (SSRIs) Zoloft and Paxil has learned of research showing that pregnant women who take SSRIs to treat their depression face a higher risk of developing dangerously high blood pressure a… Read more

The Rottenstein Law Group has learned of research showing that the fetuses of pregnant women who took SSRIs to treat their depression were twice as likely to be born preterm as the fetuses of both not-depressed pregnant women and the fetuses of women with depression that was left untreated. The study that… Read more

The Rottenstein Law Group has learned that several prominent scientists are espousing the view that—based on their review of both published and unpublished studies—antidepressants are no better than placebo for the vast majority of people with depression. One of the scientists who maintains this view is Irving Kirsch associate director of… Read more

The Rottenstein Law Group has learned that drugs in the Selective Serotonin Reuptake Inhibitor class of antidepressants can make a man who is taking SSRIs temporarily infertile. SSRIs including Zoloft can decrease a man’s sperm count by as much as 50 percent according to a Feb. 6 2012 article… Read more

The Rottenstein Law Group has learned that Pfizer Zoloft’s manufacturer has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation to consolidate for pretrial proceedings a group of cases filed against Pfizer in Pennsylvania New York Illinois Mississippi Missouri and Ohio. The stipulations of Pfizer’s motion and… Read more

The Rottenstein Law Group has learned of a new study confirming the possibility of a link between mothers who take selective serotonin reuptake inhibitors (SSRIs) including Zoloft and infants born with persistent pulmonary hypertension (PPHN). According to a Jan. 12 article on Yahoo! News a new Swedish study shows that  expectant… Read more

According to a July 4 2011 piece in the New York Times an article published in the Archives of General Psychiatry reported “an elevated risk of autism in children whose mothers took a popular type of antidepressant during the year before delivery.” These drugs so-called SSRIs include Prozac Zoloft… Read more

New research shows that babies born to women who took selective serotonin reuptake inhibitors (SSRIs) while they were pregnant may have an increased risk of congenital heart defects (that is malformations that are present at birth and change the normal flow of blood through the heart). The SSRI class of drugs includes several commonly… Read more